Abstract

Anti-aging medicine is moving away from a product-centered and appearance-reductionist model toward a preventive, functional, and biology-centered science of healthy longevity. Contemporary geroscience conceptualizes aging as a modifiable network of molecular, cellular, immune, metabolic, microbial, epigenetic, and exposomic processes rather than a passive consequence of chronological time. This narrative review substantially expands and integrates the Nanoimmunoherbogenomic framework for personalized beauty, vitality, and precision geromedicine. The framework connects five interdependent domains: nanoscale delivery systems, immune remodeling across the lifespan, standardized herbal bioactives and phytochemicals, genomic and multi-omic stratification, and biomarkerguided precision prevention. Within this model, beauty is not considered merely a visible phenotype, but a systemic readout of mitochondrial performance, immune equilibrium, redox control, dermal repair capacity, gut-skin communication, neuroendocrine stability, circadian coherence, and exposome resilience. Nanoformulation may improve solubility, chemical stability, bioavailability, tissue exposure, controlled release, and route-specific delivery of phytochemicals such as curcumin, quercetin, resveratrol, epigallocatechin gallate, thymoquinone, ginsenosides, gingerols, andrographolide, sulforaphane, berberine, fisetin, luteolin, and apigenin. However, improved delivery should not be equated with proven clinical benefit. The review therefore emphasizes translational discipline, including pharmacokinetic verification, particle characterization, safety assessment, regulatory quality, and clinically meaningful endpoints. To address the need for richer contextualization, this revised paper includes analogous cases from caloric restriction, epigenetic-clock trials, immunosenescence-oriented pilot studies, senolytic translation, lipid-nanoparticle medicine, nano-curcumin clinical trials, personalized nutrition, and skin epigenetic-clock research. Together, these cases demonstrate that the future of healthy longevity should be mechanism-informed, biomarker-conscious, clinically cautious, ethically governed, and personalized without overclaiming. The clinical aim is not the denial of aging, but the extension of healthspan, vitalityspan, skinspan, immune resilience, and meaningful functional life through evidence-informed and individualized interventions

Keywords

nanoimmunoherbogenomics, healthy longevity, precision geromedicine, inflammaging,immunosenescence, nanophytomedicine, phytochemicals, biological age, epigenetic clocks, skinspan, vitalityspan